You are here

Tab-cel

After scoring a first for an off-the-shelf CAR-T, can Atara maintain momentum?

Pharma Voice

Mon, 09/30/24 - 09:17 am

Atara Biotherapeutics

ASH: With PhIII data in hand, Atara eyes a submission to treat a small but desperate group of transplant patients

Endpoints

Mon, 12/13/21 - 11:47 pm

Upcoming events – Atara and Aslan await validating results

EP Vantage

Fri, 08/2/19 - 10:40 am

multiple sclerosis